Overview

(PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma

Status:
Terminated
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
To evaluate progression-free survival with two chemotherapy regimens on platinum-resistant/refractory ovarian and peritoneal carcinoma
Phase:
Phase 2
Details
Lead Sponsor:
Western Regional Medical Center
Treatments:
Bevacizumab
Carboplatin
Cisplatin
Gemcitabine
Oxaliplatin
Paclitaxel